Navigation Links
Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference
Date:10/24/2007

- favorable pharmacokinetic and safety data observed in first clinical

trial of novel Fleximer(TM) anticancer agent -

CAMBRIDGE, Mass., Oct. 24 /PRNewswire/ -- Mersana, a cancer therapeutics company, announced interim results of a Phase I study of its lead product candidate, XMT-1001, in patients with advanced solid tumors. The data was presented by Edward A. Sausville, M.D., Ph.D, Professor of Medicine and Associate Director for Clinical Research, University of Maryland Greenebaum Cancer Center in a poster session on October 23 at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Therapeutics taking place in San Francisco, CA. Full text of the abstract #A146 "A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients with Advanced Solid Tumors" can be viewed online at the AACR website at http://www.aacr.org. XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity.

Commenting on the data, Robert J. Fram, M.D. Chief Medical Officer at Mersana, stated: "The Phase I results show that, in humans, camptothecin, the active agent in XMT-1001, is released gradually from the Fleximer carrier as a pro-drug in a manner that will potentially avoid common safety problems associated with drugs in this class. To date, we've seen no evidence of drug-related serious adverse events and the study is ongoing."

Results were presented from 12 patients enrolled in an ongoing Phase I open-label, dose-escalation trial designed to determine the safety, tolerability and pharmacokinetic profile of XMT-1001. To date, XMT-1001 has been well tolerated in patients and no serious drug related adverse events have been reported. Preliminary results demonstrate a favorable pharmacokinetic profile with low levels of CPT, both total and free, recovered in urine. The ma
'/>"/>

SOURCE Mersana Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001 at American Association of Cancer Research Annual Meeting
2. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
3. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
4. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
5. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
6. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
7. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
8. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
9. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  There is still time ... success. The 10th Annual Institute for Supply Management ... Excellence in Supply Management is open for submissions.  ... understanding and importance of supply management by recognizing ... best supply management practices.  Entries are due August ...
(Date:7/30/2014)... July 30, 2014 Advanced Photonix ® (NYSE ... 27, 2014) financial results on Monday, August 11, 2014. A ... the close of the market and the Company will host ... 4:30 p.m. EDT on the same day. Participating ... and Director), Rob Risser (COO and Director), and ...
(Date:7/30/2014)...  Hologic, Inc. (NASDAQ: HOLX ) today ... June 28, 2014. Third Quarter Financial Highlights ... $632.6 million, reflecting operational growth of 0.5% and a ... period in the prior year. , Revenues grew ... Health revenues grew 3.5%. , GYN Surgical revenues ...
Breaking Medicine Technology:Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
(Date:7/30/2014)... 2014 Daily Gossip mentions that the "Panic ... effective way to stop anxiety and eliminate all associated symptoms. ... no less than 150,000 people in getting their lives back. ... complex anxiety treatment system that will teach sufferers different techniques ... is very simple to access, as it is available in ...
(Date:7/30/2014)... Within weeks freshman will begin to pour onto ... this will be a time of growth and the start to ... it may not be as easy as it looks. Some ... their major at least once and many will switch two or ... costs are exacerbated when switching in the later years of college. ...
(Date:7/30/2014)... 2014 New changes are in store for ... move to a new facility. The official date of the ... moving soon. , MedX Pharmacy will be moving into a ... 77581. This is the old Wells Fargo building. The new ... include a drive thru for convenient drop-off and pick-up of ...
(Date:7/30/2014)... Throughout the month of August, Restore Dental will ... Using a new technological tool called The Vue, the ... its early stages. , Oral cancer can include cancers ... other areas in and around the mouth. According to ... (SEER) program, 30 percent of oral cancers originate in ...
(Date:7/30/2014)... Ticket Down is a reputable source for ... friendly exhibition match at the Red Bull Arena in ... that was left standing as the best team in the ... largest football competition and even embarrassed the host nation Brazilian ... Germany was led by seven players that called Bayern Munich ...
Breaking Medicine News(10 mins):Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:MedX Pharmacy Relocates to New Facility 2Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 2Health News:Bayern Munich vs. Chivas Guadalajara Tickets Red Bull Arena: Ticket Down Slashes Ticket Prices for Chivas Guadalajara vs. Bayern Munich in Harrison, NJ 3
... for erection problems can face significant risks from potentially ... problems like diabetes and high blood pressure undiagnosed. That,s ... International Journal of Clinical Practice . Medical ... carried out a detailed review of the growing problem ...
... are prescribed estrogen to combat the negative effects of menopause, ... from a Tel Aviv University study suggests that hormone replacement ... from schizophrenia as well. Prof. Ina Weiner of ... Michal Arad have reported findings suggesting that restoring normal levels ...
... , ROYAL PALM BEACH, Fla. , Jan. 20 ... , MD, announced today the launch of his book, P.A.C.E.: ... Dr. Sears exposes the dangerous flaws of modern exercise advice. Dr. ... and cardio are unhealthy activities which actually reduce your lungpower, one ...
... , , FAIRFIELD, N.J. , Jan. 20 ... Inez Tenenbaum issued a statement at the APEC Toy Safety ... use of cadmium, antimony and barium in lieu of lead in children,s ... January 13, 2010 , advising that they "not allow young children ...
... , PHOENIX , Jan. 20 While emergency ... of Chances for Children, launched the "Haiti Renewal Fund" January 19 . ... of Haiti , opens with an initial matching grant of $2 ... by a subsequent $1 million from Childhelp, drawn from donations specifically ...
... , SANTA CRUZ, Calif. ... , a leading provider in medical transcription services, announced that it ... customer feedback programs to further strengthen the relationships VIVA has with ... been a priority for VIVA," stated Manuel Prado , CEO. ...
Cached Medicine News:Health News:Counterfeit Internet drugs pose significant risks and discourage vital health checks 2Health News:Counterfeit Internet drugs pose significant risks and discourage vital health checks 3Health News:Estrogen in the fight against schizophrenia 2Health News:Dr. Al Sears, MD, Reveals the Truth About Modern Exercise 2Health News:Dr. Al Sears, MD, Reveals the Truth About Modern Exercise 3Health News:CPSC & Congress Speak Out, Take Action on Heavy Metals in Children's Jewelry 2Health News:CPSC & Congress Speak Out, Take Action on Heavy Metals in Children's Jewelry 3Health News:Chances for Children Launches 'Haiti Renewal Fund' With $2 Million From Foster Friess 2Health News:Chances for Children Launches 'Haiti Renewal Fund' With $2 Million From Foster Friess 3Health News:Chances for Children Launches 'Haiti Renewal Fund' With $2 Million From Foster Friess 4Health News:VIVA Transcription Engages Satrix Solutions to Develop Customer Feedback Programs 2Health News:VIVA Transcription Engages Satrix Solutions to Develop Customer Feedback Programs 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: